Devkant sharma (32 résultats)

Etat : New.

Etat : New.

Etat : New.

Etat : New.

HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

Etat : As New. Unread book in perfect condition.

Taschenbuch. Etat : Neu. Neuware - Nanocarrier-based Drug Delivery for the Management of Fatty Liver Disease is an advanced exploration of nanotechnology-driven therapeutic strategies for the diagnosis and treatment of fatty liver disease that is positioned at the intersection of nanomedicine, pharmacology, hepatology, and drug delivery. The book begins with foundational concepts of fatty liver disease and its metabolic implications before introducing various nanocarrier-based drug delivery systems and liver-targeting strategies. Dedicated chapters discuss lipid-based nanocarriers, polymeric nanoparticles, dendrimers, and hybrid nanocarrier systems for therapeutic applications. It further explores novel therapeutics, nanocarrier-based imaging agents for diagnosis, pharmacokinetics and pharmacodynamics, and the safety and toxicity aspects of nanomedicine. Clinical translation, real-world case studies, and emerging trends in nanocarrier-assisted liver disease management are also comprehensively examined. Key Features: -Comprehensive coverage of nanocarrier systems for fatty liver disease treatment.-Discussions of lipid-based, polymeric, dendrimer, and hybrid nanocarriers.-Insights into liver-targeted drug delivery and imaging technologies.-Coverage of pharmacokinetics, toxicity, and clinical translation challenges.-Focuses on emerging therapeutic strategies and future developments in nanomedicine. …

Etat : As New. Unread book in perfect condition.

Hardback. Etat : New. New Book, Direct from Publisher.

Hardback. Etat : New. New Book, Direct from Publisher.

Buch. Etat : Neu. Neuware.

Buch. Etat : Neu. Neuware - This book presents a comprehensive exploration of the transformative potential of nanotechnology in overcoming longstanding challenges in ophthalmic drug delivery. This book brings together cutting-edge research and emerging innovations that aim to address the physiological and anatomical barriers impeding efficient drug transport to ocular tissues. Divided into thematic chapters, this book explores a wide range of nanocarrier systems, including polymeric nanoparticles, solid lipid nanoparticles, dendrimers, liposomes, niosomes, micelles, and inorganic nanomaterials, highlighting their design, mechanisms, and clinical potential. From enhancing ocular bioavailability to achieving sustained and targeted release, each chapter offers in-depth insights into the application of these technologies for treating anterior and posterior segment diseases such as glaucoma, macular degeneration, diabetic retinopathy, and dry eye syndrome. The book also explores next-generation strategies such as stimuli-responsive systems, gene delivery platforms, smart nanocarriers, and contact lens-based delivery, along with the regulatory and translational challenges that must be addressed for successful commercialization. It serves as an essential resource for pharmaceutical scientists, researchers, clinicians, and industry professionals seeking to develop patient-friendly, effective, and non-invasive ocular therapies. By combining foundational science with forward-looking perspectives, this book underscores the critical role of interdisciplinary innovation in revolutionizing ocular pharmacotherapy and shaping the future of nanomedicine in ophthalmology.…

Etat : New.

Etat : New.

Etat : New.

Etat : New. Print on Demand.

Etat : New. PRINT ON DEMAND.

Etat : New. Print on Demand.

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The process validation of dosage form is one of the most important regulatory requirements for pharmaceutical industry. It shows the documented evidence about the quality of the product by validating the whole manufacturing process. According to USFDA, proc.…

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Sharma AnjaliAnjali Sharma is presently working as Assistant Professor at Guru Gobind Singh College of Pharmacy. Her field of specialization is Pharmaceutics. She has 7 plus years of teaching experience.Devkant Sharma is presently wo.…

Etat : New. PRINT ON DEMAND.

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Sharma AnjaliDr. Anjali Sharma is presently working as Assistant Professor at Guru Gobind Singh College of Pharmacy. Her field of specialization is Pharmaceutics. Her Research areas of Novel Drug Delivery include Microsponges, Gastro.…

PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Paperback. Etat : new. Paperback. Nanocarrier-based Drug Delivery for the Management of Fatty Liver Disease is an advanced exploration of nanotechnology-driven therapeutic strategies for the diagnosis and treatment of fatty liver disease that is positioned at the intersection of nanomedicine, pharmacology, hepatology, and drug delivery. The book begins with foundational concepts of fatty liver disease and its metabolic implications before introducing various nanocarrier-based drug delivery systems and liver-targeting strategies. Dedicated chapters discuss lipid-based nanocarriers, polymeric nanoparticles, dendrimers, and hybrid nanocarrier systems for therapeutic applications. It further explores novel therapeutics, nanocarrier-based imaging agents for diagnosis, pharmacokinetics and pharmacodynamics, and the safety and toxicity aspects of nanomedicine. Clinical translation, real-world case studies, and emerging trends in nanocarrier-assisted liver disease management are also comprehensively examined. Key Features: -Comprehensive coverage of nanocarrier systems for fatty liver disease treatment.-Discussions of lipid-based, polymeric, dendrimer, and hybrid nanocarriers.-Insights into liver-targeted drug delivery and imaging technologies.-Coverage of pharmacokinetics, toxicity, and clinical translation challenges.-Focuses on emerging therapeutic strategies and future developments in nanomedicine. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …

PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.